SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Discussion centers on Lillys obesity and diabetes franchise and expectations for quarterly results, with traders pointing to Mounjaro and Zepbound demand, Foundayo uptake, and pipeline prospects. Bulls cite growth and healthcare-sector strength, while skeptics flag Lillys high valuation and competition from Novo Nordisk and emerging obesity-drug rivals.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMCs sharply reduced third-quarter outlook, driven by weak demand, excess distributor inventory and a major pricing reset, has intensified concerns about its business and heavy debt. Traders are divided between viewing the reset and debt-reduction measures as a path to recovery and fearing further deterioration or bankruptcy.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Discussion centers on whether Teladoc can show a credible turnaround in its quarterly results, especially stabilizing BetterHelp as it shifts from cash-pay to insurance amid concerns about declining revenue, profitability and management execution. Bulls cite potential insurance growth, Teladoc One and short-interest dynamics, while skeptics remain doubtful; squeeze claims are speculative.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens attention is centered on Phase 3 results showing IMDELLTRA with AstraZenecas IMFINZI reduced the risk of death in first-line extensive-stage small-cell lung cancer. Traders are treating the survival findings as a positive oncology catalyst, while some also point to favorable Phase 3 TEZSPIRE results in eosinophilic esophagitis.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Speculation that Johnson & Johnson could acquire Sellas Life Sciences is a recurring topic, with traders pointing to alleged executive connections and J&Js oncology ambitions; no deal has been confirmed. Traders are also debating J&Js earnings reaction: stronger-than-expected results and raised guidance were offset by weak MedTech growth and litigation concerns, while some view the pullback as a buying opportunity.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZenecas oncology and rare-disease pipeline is drawing attention, with traders highlighting the U.S. launch of lung-cancer drug Zegfrovy, an accelerated FDA approval for Ultomiris in IgA nephropathy, and positive trial updates. Reactions are mixed between optimism about new treatment opportunities and concern about recent trial setbacks and share-price weakness.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons breakout to record highs is drawing attention as firm crude prices and Middle East supply concerns support energy stocks, with traders also positioning ahead of the companys earnings report. Sentiment is largely bullish around the momentum, though some caution that the rally is extended and the results could test whether it can hold.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

The ongoing shale-oil antitrust case is drawing attention after the judge deferred jurisdictional rulings for Hess and Pioneer pending limited discovery, with an October status conference ahead; traders emphasize that the claims remain unresolved. Bullish chatter also points to oil-linked strength and a possible technical breakout, though some traders are watching resistance.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is drawing attention around GameStops nearly 10% stake and its rejected takeover bid, with traders debating whether GameStop will renew its acquisition push, seek a partnership or board influence, or step back. Speculation is tempered by doubts about financing and deal merits, while some traders also cite eBays earnings and analyst support.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is drawing attention amid volatile crude prices and Middle East supply concerns, especially reports involving Iran and Strait of Hormuz shipping. Traders are bullish on the potential benefit to producers but debate why energy shares often lag oil, while ceasefire and deal speculation has raised concerns that the geopolitical risk premium could fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nebius Says It Is ‘Sequencing’ Its Financing After Getting $3.5B From Citi, With Bigger Asset-Backed Loans Still to Come

Equity

The Nvidia-backed company said proceeds will go toward data center development, GPU purchases and general corporate purposes. 


Nebius Less Exposed To AI Cloud Debt Concerns, Says CRO Marc Boroditsky — Piper Sandler Cuts Target 22%

Boroditsky said developments affecting other players were weighing on NBIS stock price. He believes the market will return to more normal conditions as investors recognize Nebius' financing structure.

A Guide to AI ETF Investment

AI spending is expected to hit $2.7 trillion in 2026 as adoption accelerates. Explore four AI ETFs with year-to-date gains of up to 58.3%.

Jensen Huang Calls OpenAI ‘One Of The Most Consequential Companies In History’ – Says It Can 'Use Whatever Part' Of OpenShell It Wants

In an interview with CNBC, the Nvidia CEO said OpenAI’s leadership team, including Sam Altman, Greg Brockman, Sarah Friar and Nick Turley, “do a terrific job running the company.”


The Zacks Analyst Blog Highlights CHAT, BWET, BNO, AIS, EWY and FTXL

CHAT and other ETFs surged in 2026 as AI demand, geopolitical shocks and energy disruptions drove sharp gains.

5 ETF Areas That Have Nearly Doubled in First Nine Months of 2026

Geopolitical tensions, oil shocks and the AI boom have fueled huge ETF gains in 2026. Explore five ETF areas up at least 85%. 

Roundhill CEO Dave Mazza Says Memory Trade Is Back To Fundamentals — Micron Earnings A ‘Real Tone Setter’

In an interview with CNBC, Mazza said a sharp reset has reduced leverage in memory trades, while investors are broadening their focus across more specialized parts of the AI trade.

Trump Says US Already Has The Power To Rein In AI Firms – ‘There Is A Sick Conspiracy Going On Against AI And Data Centers’

Trump warned that restrictions on AI and data-center development could strengthen China’s competitive position.

Bet on These 3 AI ETFs to Beat the September Curse

AI ETFs offer diversified exposure to a booming industry, giving investors a way to navigate September volatility while staying invested in AI's growth.

The Zacks Analyst Blog Highlights NVIDIA,CHAT, AIS, AIQ,  QTUM, ROBO and  IGPT

NVIDIA???s 70% fiscal 2028 growth outlook signals surging AI demand, putting broad-based AI ETFs in focus.

Tidal Trust II - Roundhill Generative AI & Technology ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Chief Operating Officer Ophir Nave said the Citi funding shows Nebius can choose “when and how we raise capital.”&nbsp;</li><li>According to him, the loan supports the company’s near-term buildout, with larger financing still ahead.</li><li>He said the company has $40 billion in long-term customer contracts that could serve as collateral.&nbsp;</li></ul>Nebius (NBIS) shares dipped in morning trade on Thursday amid the broader market sell-off after the company announced it had secured a $3.5 billion senior secured facility from Citi.&nbsp;Chief Operating Officer Ophir Nave said it shows the Nvidia (NVDA)-backed company can choose “when and how we raise capital.” The loan supports the near-term buildout, he said, and larger financing is still ahead.“Sequencing our financing is how we optimize our long-term cost of capital,” Nave stated. “We still have a range of capital sources available to us to finance the next phase of growth.” He added that the company currently has $40 billion in long-term customer contracts that could be used for collateral.&nbsp;<a href="https://stocktwits.com/symbol/NBIS">NBIS stock</a> fell as much as 2.5% in pre-market trade and was among the top trending tickers on Stocktwits at the time of writing, with retail traders debating whether the new loan aids the company’s AI build out or increases debt risk.<h2 class="st-heading-2">Nebius Short-Term Funding&nbsp;</h2>The facility matures in 364 days and initially carries an interest rate of Term SOFR plus 2.75%, rising to a maximum of 3.50%, subject to other adjustments. Nebius said proceeds will go toward data center development, GPU purchases and general corporate purposes.&nbsp;However, the loan comes amid mounting pressure on the neocloud sector. Investors have become more cautious about the debt required to finance rapid expansion, with CoreWeave (CRWV) at the center of the recent market turmoil.<h2 class="st-heading-2">Neocloud Credit Concerns</h2>CoreWeave lost roughly a quarter of its market value last week during a sharp sell-off in its shares and bonds. Yields on some of its bonds climbed to around 15%, up from about 9.675% when the debt was issued last year.Both NBIS stock and CRWV shares have fallen nearly 30% this month amid the sell-off. Piper Sandler cut its price target on Nebius by 22% to $185 on Wednesday, warning that neocloud stocks could remain “in the penalty box” until the financing outlook becomes clearer. Gartner has predicted that more than 80% of neocloud providers will cease operating independently by 2030.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20261022_080227281_f26c66e73d.png" alt="koyfin_20261022_080227281.png" width="2400" height="1240"><figcaption>NBIS, CRWV stocks price performance month-to-date on October 22, as of 8:00 a.m. ET. | Source: Kofyin</figcaption></figure>“We caught a lot of hate when we initiated CRWV with a $56 price target seven months ago,” Bernstein told CNBC on Thursday. “Today, it’s a lot harder to find bulls — certainly some of them just don’t call us anymore.” The firm reiterated its ‘Underweight’ rating on CoreWeave.&nbsp;<h2 class="st-heading-2">How Is Retail Feeling About NBIS Stock?</h2>On Stocktwits, retail sentiment around Nebius trended in ‘extremely bullish’ territory over the past day, accompanied by chatter at ‘extremely high’ levels. Platform data showed that message volume around the shares has more than doubled over the past week.<figure class="image"><img src="https://news.stocktwits-cdn.com/image_28_84d7e422d3.png" alt="image (28).png" width="1286" height="686"><figcaption>NBIS stock retail sentiment on October 22 as of 8:00 a.m. ET | Source: Stocktwits</figcaption></figure>One retail trader stated that although sentiment toward data center companies had deteriorated, Nebius remained one of the strongest businesses among major neocloud providers.&nbsp;<stembedurl>https://stocktwits.com/Bull4life24/message/667072469</stembedurl>Another trader said the Citi financing could help push NBIS shares back above $180. <stembedurl>https://stocktwits.com/Unusualtable/message/667093255</stembedurl>NBIS stock is still up 90% this year despite the recent AI selloff, which puts the shares over 70% below its record high of over $299 seen in June.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nvidia-jensen-huang-ai-chips-financeable-asset-neocloud-demand-is-off-the-charts/cZxw3N7RBwo">Nvidia’s Jensen Huang Wants AI Chips To Be A ‘Financeable Asset,’ Says Neocloud Demand Is ‘Off The Charts’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Nebius Group logo is seen displayed on a smartphone screen with a green circuit board in the background. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Nebius (NBIS) shares dipped in morning trade on Thursday amid the broader market sell-off after the company announced it had secured a $3.5 billion senior secured facility from Citi.

Nebius Secures $3.5B From Citi, Says Larger Asset-Backed Loans Are Still Ahead

Roundhill Generative AI & Technology ETF

CoreWeave Inc

Nebius Group N.V.

Invesco NASDAQ 100 ETF

First Trust Exchange-Traded Fund III - First Trust NASDAQ-100 Technology Sector Index Fund

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

$CHAT not sure how this thing is up after hours considering the majority of the stocks in the ETF are all negative after hours... MAKE IT MAKE SENSE!

Feed

News

Sentiment

Fundamentals

Info

CHAT Roundhill Generative AI & Technology ETF

Fundamentals

Latest CHAT News